- Conditions
- Dry Eye
- Interventions
- loteprednol etabonate ophthalmic suspension, 0.5%, vehicle of loteprednol etabonate
- Drug
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 643
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Dry Eye
- Interventions
- Cyclosporin 0.05% emulsion, Endura, Refresh artificial tears
- Drug
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 4 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Keratoconjunctivitis Sicca, Dry Eye Syndromes, Ocular Surface Disease, Sjogren's Syndrome
- Interventions
- Questionnaires, Tear fluid sampling, Impression Cytology
- Diagnostic Test
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 92 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Dry Eye
- Interventions
- PEG-400 based artificial tear, Systane
- Drug
- Lead sponsor
- Bp Consulting, Inc
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 70 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Boynton Beach, Florida
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- Retaine™
- Drug
- Lead sponsor
- Ocusoft, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 1
- States / cities
- Andover, Massachusetts
- Conditions
- Dry Eye Syndrome
- Interventions
- TheraTears lubricating drops
- Other
- Lead sponsor
- Jenkins Eye Care
- Other
- Eligibility
- 21 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Honolulu, Hawaii
- Conditions
- Keratoconjunctivitis Sicca
- Interventions
- Rebamipide 1%, Rebamipide 2%, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 755 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 63
- States / cities
- Birmingham, Alabama • Glendale, Arizona • Peoria, Arizona + 55 more
- Conditions
- Dry Eye Disease, Meibomian Gland Dysfunction
- Interventions
- Protection of eyes with tinted soft scleral eye shields
- Combination Product
- Lead sponsor
- Lumenis Be Ltd.
- Industry
- Eligibility
- 22 Years to 120 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
- Conditions
- Dry Eye Disease (DED)
- Interventions
- CyclASol Ophthalmic Solution
- Drug
- Lead sponsor
- Novaliq GmbH
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 14
- States / cities
- Los Angeles, California • Newport Beach, California • Carmel, Indiana + 11 more
- Conditions
- Meibomian Gland Dysfunction, Evaporative Dry Eye Disease
- Interventions
- Systane iLux® Dry Eye System, LipiFlow® Thermal Pulsation System
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 299 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 15
- States / cities
- Long Beach, California • Los Angeles, California • San Diego, California + 12 more
- Conditions
- Dry Eye Disease
- Interventions
- ST-100 (vezocolmitide), Vehicle
- Drug
- Lead sponsor
- ORA, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 175 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Dry Eye
- Interventions
- Cataract Surgery and Limbal relaxing incision
- Procedure
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Long Island City, New York
- Conditions
- Dry Eye Disease
- Interventions
- Naltrexone, Placebos
- Drug
- Lead sponsor
- Sassani, Joseph S., MD, MHA
- Individual
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Memphis, Tennessee
- Conditions
- Dry Eye
- Interventions
- Visant Medical Canalicular Plug, Commercially available canalicular plug
- Device
- Lead sponsor
- Visant Medical, Inc.
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 156 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2020 – 2022
- U.S. locations
- 5
- States / cities
- Scottsdale, Arizona • Newport Beach, California • Andover, Massachusetts + 2 more
- Conditions
- Dry Eye
- Interventions
- B & L Soothe Lubricant Eye Drops, Liposic EDO, OcuFresh Eye Wash
- Drug
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 30 Years to 75 Years
- Enrollment
- 20 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Tomography
- Interventions
- UNITY DX, ANTERION
- Device
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 22 Years and older
- Enrollment
- 110 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Dry Eye Disease, Dry Eye Syndrome
- Interventions
- AGN-242428, AGN-231868, AGN-242428 Vehicle, AGN-231868 Vehicle, Lifitegrast 5% Ophthalmic Solution
- Drug · Other
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 292 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 11
- States / cities
- Phoenix, Arizona • Newport Beach, California • Colorado Springs, Colorado + 8 more
- Conditions
- Congenital Heart Block, Neonatal Lupus, Autoantibody-associated Heart Block
- Interventions
- intravenous immune globulin (IVIG)
- Drug
- Lead sponsor
- NYU Langone Health
- Other
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 2
- States / cities
- Livingston, New Jersey • New York, New York
- Conditions
- Dry Eye Syndromes
- Interventions
- Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®), Artificial Tears REFRESH ENDURA®
- Drug
- Lead sponsor
- Allergan
- Industry
- Eligibility
- 21 Years to 50 Years
- Enrollment
- 137 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Dry Eye Syndrome, Healthy
- Interventions
- Environmental Chamber Condition Change Intervention
- Other
- Lead sponsor
- University of Rochester
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- Rochester, New York
- Conditions
- Sjogren's Syndrome
- Interventions
- Dazodalibep, Placebo
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 651 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 37
- States / cities
- Avondale, Arizona • Chandler, Arizona • Flagstaff, Arizona + 34 more
- Conditions
- Dry Eye Disease, Meibomian Gland Dysfunction
- Interventions
- Sunflower lecithin, Olive oil
- Dietary Supplement
- Lead sponsor
- George Washington University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Dry Eye Syndrome
- Interventions
- IPL, Sham IPL, MGX
- Device · Procedure
- Lead sponsor
- Lumenis Be Ltd.
- Industry
- Eligibility
- 22 Years to 85 Years
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 2
- States / cities
- Nashville, Tennessee • Austin, Texas
- Conditions
- Dry Eye
- Interventions
- Vehicle, SDP-4 Ophthalmic Solution (1.0%)
- Drug
- Lead sponsor
- Silk Technologies, Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 5
- States / cities
- Garden Grove, California • Murrieta, California • Newport Beach, California + 2 more